New View Surgical Secures $2.5M Series A Funding to Advance VisionPort, an Innovative Imaging and Access System for Minimally Invasive Surgery

VCBeat (WeChat ID: vcbeat) learned from foreign media that on June 17, U.S. local time, medical device company New View Surgical completed a $2.5 million Series A financing round. The funds from this round will be used to support the company’s research and development of minimally invasive surgical assistance devices and to optimize surgical workflows.

It is reported that this round of financing was jointly invested by New York Angels, Mid Atlantic Bio Angels, Keiretsu Forum, and others.

New View Surgical, established in 2009 and headquartered in Massachusetts, USA, is a medical device company.

VisionPort System is the flagship product of New View Surgical, Inc. It is a novel surgical imaging and access system designed for minimally invasive surgery. This technology aims to simplify laparoscopic procedures across all specialties by reducing the need for separate camera ports and camera holders, while enabling tracked visualization of the surgical process.

The single VisionPort device integrates the laparoscope, camera, light source, and access port into a single instrument. By visualizing the surgical workflow, it enables surgeons to monitor the entire procedure, thereby ensuring surgical accuracy and enhancing the efficiency of the entire surgical team.

Compared with traditional surgery, the application of VisionPort technology can optimize surgical procedures. In traditional surgery, because surgeons cannot observe a complete view of the patient’s internal anatomy, multiple incisions are often required to complete more complex procedures. However, VisionPort enables panoramic visualization of pathological tissues within the human body through a single incision, allowing surgeons to determine whether additional incisions are necessary based on the acquired images. This not only addresses the limitations inherent in traditional surgical approaches but also reduces patients’ postoperative recovery time.

Bryce Klontz, President and CEO of New View Surgical, stated, “We are deeply grateful for the support from our new round of investors. The company will leverage this investment to bring its surgical technologies to market, with the aim of reducing healthcare costs and advancing surgical imaging capabilities. We look forward to collaborating with both new and existing investors to deliver high-quality minimally invasive surgical solutions to more patients worldwide.”

New York Angels, established in 2004 and headquartered in New York, USA, is the successor organization to the NYNMA (New York New Media Association) Angel Investment Program. It is a membership organization comprising more than 110 active angel investors and early-stage venture capital funds. Since 2002, its members have invested over $100 million in more than 90 companies.

Mid Atlantic Bio Angels Group (MABA) is an angel investment group focused on emerging life sciences companies. MABA’s members include invited group members, active accredited investors seeking to invest in life sciences companies, as well as institutional investors and life sciences companies interested in collaborating with angel investors.

Keiretsu Forum, established in 2000, is an angel investor group headquartered in California, USA. It focuses on providing early-stage, seed-stage, and late-stage equity investments as well as debt financing for companies, having completed 114 investments to date.

(Compiled by Liu Yujing)